SCHEMBL18800760

SCHEMBL18800760

COc1cccc(-c2cnc(Nc3ccccc3Cl)c(N)c2C(=N)N)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 3/20 0.61
▸ ADORA2A P29274 2/20 0.47
▸ ADORA1 P30542 2/20 0.47
▸ DHODH Q02127 1/20 0.42
▸ HSD17B10 Q99714 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ SRC P12931 2/20 0.39
▸ PDGFRB P09619 1/20 0.39
▸ FGFR1 P11362 1/20 0.39
▸ PDGFRA P16234 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CLK1 P49759 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18800468 0.89 BTK (0.49) BTKADORA2AADORA1DHODHHSD17B10
SCHEMBL18800563 0.86 BTK (0.58) BTKADORA2AADORA1HSD17B10MAPT
SCHEMBL18800466 0.83 DHODH (0.42) BTKADORA2AADORA1DHODHHSD17B10
SCHEMBL18800786 0.81 RAPGEF4 (0.44) BTKADORA2AADORA1DHODHHSD17B10
SCHEMBL18800792 0.80 BTK (0.47) BTKADORA2AADORA1DHODHMAPT
SCHEMBL18800891 0.79 BTK (0.62) BTKADORA2AADORA1DHODHMAPT
SCHEMBL18800784 0.78 BTK (0.46) BTKADORA2AADORA1DHODH
SCHEMBL18800559 0.78 BTK (0.58) BTKMAPTMAPK1TP53SRC
SCHEMBL8402235 0.76 BTK (0.75) BTKADORA2AADORA1MAPTTP53
SCHEMBL18800772 0.76 ADORA1 (0.43) BTKADORA1HSD17B10MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2789615-B1 Azaindazoles as Btk kinase modulators and use thereof BRISTOL MYERS SQUIBB CO (US) 2017-05-03 — — EP disclosed
Send feedback